These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31821596)

  • 1. LRRK2 regulates endoplasmic reticulum-mitochondrial tethering through the PERK-mediated ubiquitination pathway.
    Toyofuku T; Okamoto Y; Ishikawa T; Sasawatari S; Kumanogoh A
    EMBO J; 2020 Jan; 39(2):e100875. PubMed ID: 31821596
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Wauters F; Cornelissen T; Imberechts D; Martin S; Koentjoro B; Sue C; Vangheluwe P; Vandenberghe W
    Autophagy; 2020 Feb; 16(2):203-222. PubMed ID: 30945962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.
    Bonello F; Hassoun SM; Mouton-Liger F; Shin YS; Muscat A; Tesson C; Lesage S; Beart PM; Brice A; Krupp J; Corvol JC; Corti O
    Hum Mol Genet; 2019 May; 28(10):1645-1660. PubMed ID: 30629163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small heterodimer partner (SHP) aggravates ER stress in Parkinson's disease-linked LRRK2 mutant astrocyte by regulating XBP1 SUMOylation.
    Lee JH; Han JH; Joe EH; Jou I
    J Biomed Sci; 2021 Jul; 28(1):51. PubMed ID: 34229656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein.
    Niu J; Yu M; Wang C; Xu Z
    J Neurochem; 2012 Aug; 122(3):650-8. PubMed ID: 22639965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity.
    Stormo AED; Shavarebi F; FitzGibbon M; Earley EM; Ahrendt H; Lum LS; Verschueren E; Swaney DL; Skibinski G; Ravisankar A; van Haren J; Davis EJ; Johnson JR; Von Dollen J; Balen C; Porath J; Crosio C; Mirescu C; Iaccarino C; Dauer WT; Nichols RJ; Wittmann T; Cox TC; Finkbeiner S; Krogan NJ; Oakes SA; Hiniker A
    J Cell Biol; 2022 Apr; 221(4):. PubMed ID: 35266954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant mitochondrial morphology and function associated with impaired mitophagy and DNM1L-MAPK/ERK signaling are found in aged mutant Parkinsonian LRRK2
    Liu H; Ho PW; Leung CT; Pang SY; Chang EES; Choi ZY; Kung MH; Ramsden DB; Ho SL
    Autophagy; 2021 Oct; 17(10):3196-3220. PubMed ID: 33300446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants.
    Verma M; Callio J; Otero PA; Sekler I; Wills ZP; Chu CT
    J Neurosci; 2017 Nov; 37(46):11151-11165. PubMed ID: 29038245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast Biomarkers of Sporadic Parkinson's Disease and LRRK2 Kinase Inhibition.
    Smith GA; Jansson J; Rocha EM; Osborn T; Hallett PJ; Isacson O
    Mol Neurobiol; 2016 Oct; 53(8):5161-77. PubMed ID: 26399642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkin recruitment to impaired mitochondria for nonselective ubiquitylation is facilitated by MITOL.
    Koyano F; Yamano K; Kosako H; Tanaka K; Matsuda N
    J Biol Chem; 2019 Jun; 294(26):10300-10314. PubMed ID: 31110043
    [No Abstract]   [Full Text] [Related]  

  • 11. LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson's disease.
    Howlett EH; Jensen N; Belmonte F; Zafar F; Hu X; Kluss J; Schüle B; Kaufman BA; Greenamyre JT; Sanders LH
    Hum Mol Genet; 2017 Nov; 26(22):4340-4351. PubMed ID: 28973664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity.
    Kalogeropulou AF; Zhao J; Bolliger MF; Memou A; Narasimha S; Molitor TP; Wilson WH; Rideout HJ; Nichols RJ
    Biochem J; 2018 Apr; 475(7):1271-1293. PubMed ID: 29519959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitofusin-mediated ER stress triggers neurodegeneration in pink1/parkin models of Parkinson's disease.
    Celardo I; Costa AC; Lehmann S; Jones C; Wood N; Mencacci NE; Mallucci GR; Loh SH; Martins LM
    Cell Death Dis; 2016 Jun; 7(6):e2271. PubMed ID: 27336715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of ER-mitochondria contacts by Parkin via Mfn2.
    Basso V; Marchesan E; Peggion C; Chakraborty J; von Stockum S; Giacomello M; Ottolini D; Debattisti V; Caicci F; Tasca E; Pegoraro V; Angelini C; Antonini A; Bertoli A; Brini M; Ziviani E
    Pharmacol Res; 2018 Dec; 138():43-56. PubMed ID: 30219582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization.
    Papkovskaia TD; Chau KY; Inesta-Vaquera F; Papkovsky DB; Healy DG; Nishio K; Staddon J; Duchen MR; Hardy J; Schapira AH; Cooper JM
    Hum Mol Genet; 2012 Oct; 21(19):4201-13. PubMed ID: 22736029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated Interorganellar Crosstalk of Mitochondria in the Pathogenesis of Parkinson's Disease.
    Sironi L; Restelli LM; Tolnay M; Neutzner A; Frank S
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes.
    Lee JH; Han JH; Kim H; Park SM; Joe EH; Jou I
    Acta Neuropathol Commun; 2019 May; 7(1):68. PubMed ID: 31046837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase.
    Ho DH; Kim H; Nam D; Sim H; Kim J; Kim HG; Son I; Seol W
    Cell Biochem Funct; 2018 Dec; 36(8):431-442. PubMed ID: 30411383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ULK1 and JNK are involved in mitophagy incurred by LRRK2 G2019S expression.
    Zhu Y; Wang C; Yu M; Cui J; Liu L; Xu Z
    Protein Cell; 2013 Sep; 4(9):711-21. PubMed ID: 27023913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity.
    Ko HS; Bailey R; Smith WW; Liu Z; Shin JH; Lee YI; Zhang YJ; Jiang H; Ross CA; Moore DJ; Patterson C; Petrucelli L; Dawson TM; Dawson VL
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2897-902. PubMed ID: 19196961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.